as 11-18-2024 4:00pm EST
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).
Founded: | 1956 | Country: | United States |
Employees: | N/A | City: | WALTHAM |
Market Cap: | 211.0B | IPO Year: | N/A |
Target Price: | $651.56 | AVG Volume (30 days): | 1.6M |
Analyst Decision: | Strong Buy | Number of Analysts: | 19 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 15.95 | EPS Growth: | 4.56 |
52 Week Low/High: | $465.90 - $627.88 | Next Earning Date: | 10-23-2024 |
Revenue: | $42,370,000,000 | Revenue Growth: | -2.42% |
Revenue Growth (this year): | 0.84% | Revenue Growth (next year): | 5.38% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
CASPER MARC N | TMO | Chairman & CEO | Nov 8 '24 | Sell | $552.95 | 9,000 | $4,975,765.28 | 22,350 | |
CASPER MARC N | TMO | Chairman & CEO | Nov 6 '24 | Sell | $558.28 | 20,000 | $11,158,768.34 | 22,350 |
TMO Breaking Stock News: Dive into TMO Ticker-Specific Updates for Smart Investing
Zacks
11 hours ago
Simply Wall St.
21 hours ago
GuruFocus.com
4 days ago
MT Newswires
4 days ago
Business Wire
4 days ago
MedTech Dive
4 days ago
Simply Wall St.
5 days ago
GuruFocus.com
6 days ago
The information presented on this page, "TMO Thermo Fisher Scientific Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.